Recruiting NA Atherosclerosis Cardiovascular Disease

New treatment option for Atherosclerosis Cardiovascular Disease

Official title Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles.

ClinicalTrials.gov ID: NCT07361887

What this study is testing

What it's testing
This study aims to investigate how moderate wine consumption influences circulating extracellular vesicles (EVs) in healthy adults. EVs are small particles released by cells that carry proteins, lipids, and genetic material, and play important roles in communication between cells.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 35 to 36. Healthy volunteers may be eligible.

You may be able to join if

  • Healthy adult men and women aged 35 to 65 years.
  • Body Mass Index (BMI) between 18.5 and 29.9 kg/m².
  • Non-smokers or ex-smokers for at least 12 months.
  • Moderate alcohol consumers, defined as ≤2 units/day for men and ≤1 unit/day for women.
  • Normal fasting glucose and lipid profile at screening.

You likely can't join if

  • History or clinical evidence of cardiovascular, hepatic, renal, thyroid, gastrointestinal, or metabolic diseases (including diabetes, dyslipidemia...
  • Use of medications or supplements known to affect glucose, lipid, or inflammatory metabolism (e.g., statins, corticosteroids, anti-inflammatory...
  • Pregnancy or breastfeeding.
  • Recent blood donation (within the last 3 months) or planned blood donation during the study period.
  • Major weight change (\>5% of body weight) within the last 3 months.
  • Participation in another clinical or biomedical study within the previous 3 months.
See the full eligibility criteria
Who can join
  • Healthy adult men and women aged 35 to 65 years.
  • Body Mass Index (BMI) between 18.5 and 29.9 kg/m².
  • Non-smokers or ex-smokers for at least 12 months.
  • Moderate alcohol consumers, defined as ≤2 units/day for men and ≤1 unit/day for women.
  • Normal fasting glucose and lipid profile at screening.
  • Willing and able to refrain from alcohol, polyphenol-rich foods, and intense exercise for 48 hours before each study visit.
  • Able to understand the study procedures and provide written informed consent.
What rules you out
  • History or clinical evidence of cardiovascular, hepatic, renal, thyroid, gastrointestinal, or metabolic diseases (including diabetes, dyslipidemia, or hypertension).
  • Use of medications or supplements known to affect glucose, lipid, or inflammatory metabolism (e.g., statins, corticosteroids, anti-inflammatory drugs).
  • Pregnancy or breastfeeding.
  • Recent blood donation (within the last 3 months) or planned blood donation during the study period.
  • Major weight change (\>5% of body weight) within the last 3 months.
  • Participation in another clinical or biomedical study within the previous 3 months.
  • Known allergy or intolerance to wine, alcohol, or its components (e.g., sulfites).
  • History of alcohol abuse or inability to abstain from alcohol outside the study context.
  • Reluctance to receive information about incidental health findings arising from the study.
  • Any condition judged by the investigators to limit compliance or increase study risk (e.g., psychiatric disorders, inability to adhere to fasting requirements).

The study team makes the final eligibility decision.

Where it's taking place

  • Seville, Sevilla, Spain

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 35 years to 36 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Seville, Sevilla, Spain. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.